Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
What is missing There is no published human pharmacokinetic study of subcutaneous AOD-9604, no published human topical or intranasal exposure data, no Phase 3 efficacy trial, no long-term safety data beyond 24 weeks, and no published human cartilage or joint outcome data
The best-studied in this respect is lycopene
Half-life following IM or IV is under 30 minutes rapid clearance
Im a Longevity Doctor
US$ 26.71
US$ 22.42
US$ 22.06
US$ 22.65
US$ 29.06
US$ 20.65
US$ 26.95
US$ 27.76
US$ 28.27
US$ 21.62
US$ 20.78
US$ 27.23
